SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-014200
Filing Date
2022-07-19
Accepted
2022-07-19 18:58:02
Documents
2
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1731
2 poa_kelly.htm EX-24 5173
  Complete submission text file 0001567619-22-014200.txt   8327
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142
Business Address
Kelly-Croswell Lisa (Reporting) CIK: 0001845596 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 221092501